These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16079929)

  • 21. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
    Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity and distribution of plasma platelet-activating factor acetylhydrolase in women with gestational diabetes mellitus and their neonates.
    Gao Q; He GL; Zhang L; Bai H; Liu XH; Fan P
    Diabetes Metab Res Rev; 2016 Sep; 32(6):634-42. PubMed ID: 26789131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto A; Saitta C; Bitto A; Castaldo M; Cinquegrani M; Bonaiuto M; Cristadoro S; Saitta A
    Aging Clin Exp Res; 2008 Apr; 20(2):171-7. PubMed ID: 18431085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
    Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
    Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal and fetal plasma platelet-activating factor acetylhydrolase activity and distribution in pre-eclampsia.
    Fan P; Liu XH; He GL; Zhang S; Zhang JX; Bai H
    Pediatr Res; 2012 Oct; 72(4):426-31. PubMed ID: 22797139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.
    De Geest B; Stengel D; Landeloos M; Lox M; Le Gat L; Collen D; Holvoet P; Ninio E
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E68-75. PubMed ID: 11031226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus.
    Cederholm A; Svenungsson E; Stengel D; Fei GZ; Pockley AG; Ninio E; Frostegård J
    Arthritis Rheum; 2004 Sep; 50(9):2869-76. PubMed ID: 15457454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The paraoxonase 1 (PON1), platelet-activating factor acetylohydrolase (PAF-AH) and dimethylarginine dimethylaminohydrolase (DDAH) activity in the metformin treated normal and diabetic rats.
    Wójcicka G; Jamroz-Wiśniewska A; Czechowska G; Korolczuk A; Marciniak S; Bełtowski J
    Eur J Pharmacol; 2016 Oct; 789():187-194. PubMed ID: 27450486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity.
    Tselepis AD; Elisaf M; Besis S; Karabina SA; Chapman MJ; Siamopoulou A
    Arthritis Rheum; 1999 Feb; 42(2):373-83. PubMed ID: 10025933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
    Fan P; Liu H; Wang Y; Zhang F; Bai H
    Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.
    Wójcicka G; Jamroz-Wiśniewska A; Marciniak A; Łowicka E; Bełtowski J
    Life Sci; 2010 Jul; 87(3-4):126-32. PubMed ID: 20638992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.
    Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Miltiadous G; Goudevenos JA; Cariolou MA; Chapman MJ; Tselepis AD; Elisaf M
    J Lipid Res; 2002 Feb; 43(2):256-63. PubMed ID: 11861667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of serum acetyl hydrolase (PAF-AH) and paraoxonase 1 (PON1) values between prostate cancer patients and a control group.
    Benli E; Bayrak A; Cirakoglu A; Bayrak T; Noyan T
    Kaohsiung J Med Sci; 2017 Nov; 33(11):572-577. PubMed ID: 29050675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation.
    Okamura K; Miura S; Zhang B; Uehara Y; Matsuo K; Kumagai K; Saku K
    Circ J; 2007 Feb; 71(2):214-9. PubMed ID: 17251670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome.
    Fan P; Liu HW; Wang XS; Zhang F; Song Q; Li Q; Wu HM; Bai H
    Hum Reprod; 2010 May; 25(5):1288-94. PubMed ID: 20185515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation.
    Kaur HD; Bansal MP
    Lipids Health Dis; 2009 Dec; 8():55. PubMed ID: 20015371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.
    Eisaf M; Tselepis AD
    Biochem Pharmacol; 2003 Dec; 66(11):2069-73. PubMed ID: 14609731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits.
    Arakawa H; Qian JY; Baatar D; Karasawa K; Asada Y; Sasaguri Y; Miller ER; Witztum JL; Ueno H
    Circulation; 2005 Jun; 111(24):3302-9. PubMed ID: 15956136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
    Marathe GK; Zimmerman GA; McIntyre TM
    J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.